Table 3 Characteristics of patients with oral sequential treatment
Non-OST (n = 41) | OST (n = 36) | P | |
|---|---|---|---|
Age, mean years (IQR) | 71 (58–82) | 75 (66–80) | 0.617 |
Male, n (%) | 24 (59) | 33 (92) | 0.001 |
Comorbidities, n (%) | |||
- ischemic heart disease - dementia - COPD - diabetes mellitus - chronic kidney failure - solid tumour | 3 (7) 5 (12) 6 (15) 4 (10) 5 (12) 11 (27) | 8 (22) 3 (8) 3 (8) 8 (22) 4 (11) 12 (33) | 0.101 0.717 0.490 0.208 0.999 0.621 |
Charlson index ≥ 3, n (%) | 21 (51) | 11 (31) | 0.104 |
Source of infection, n (%) | |||
- urinary - catheter - respiratory - abdominal - surgical wound - cutaneous - unknown | 12 (29) 7 (17) 2 (5) 6 (15) 1 (2) 0 3 (7) | 14 (39) 4 (11) 0 2 (6) 3 (8) 1 (3) 1 (3) | 0.470 0.528 0.496 0.271 0.335 0.468 0.618 |
Sepsis, n (%) | 23 (56) | 11 (31) | 0.038 |
ICU admission, n (%) | 11 (27) | 5 (14) | 0.260 |
P-T/CEF, n (%) | 23 (56) | 32 (89) | 0.002 |
Adverse events, n (%) | 2 (5) | 0 | 0.496 |
In-hospital stay (IQR) | 18 (13–38) | 14 (7–22) | 0.005 |
Recurrence, n (%) | 2 (5) | 1 (3) | 0.999 |